ConductScience.org, home

Paper2693045

Epoetin (recombinant human erythropoietin). A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in anaemia and the stimulation of erythropoiesis.

Faulds D and 1 other. Drugs, 1989. Cited by 83 papers, by iCite.

Cite this record

ConductScience Library. Epoetin (recombinant human erythropoietin). A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in anaemia and the stimulation of erythropoiesis. Papers, record 2693045. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2693045

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Epoetin (recombinant human erythropoietin). A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in anaemia and the stimulation of erythropoiesis.
PubMed
Journal
Drugs
PubMed
Year
1989
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
83
iCite
Relative citation ratio, by iCite
3.04
iCite
Revised in PubMed
2026-10-11
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Faulds DD
2Sorkin EME M

Source PubMed

Download CSV of authors

Topics5

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AnemiaMajor topic
ErythropoiesisMajor topic
ErythropoietinMajor topic
Humans
Recombinant Proteins

References123

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
12879127Potential side-effects of erythropoietin.Lancet1987https://conductscience.org/library/papers/2879127PubMed
23373403Responsiveness to recombinant human erythropoietin of marrow erythroid progenitors from infants with the "anemia of prematurity".J Pediatr1988https://conductscience.org/library/papers/3373403PubMed
33278599Recombinant human erythropoietin: implications for nephrology.Am J Kidney Dis1988https://conductscience.org/library/papers/3278599PubMed
42915778[Assay methods for erythropoietin].Nephron1989https://conductscience.org/library/papers/2915778PubMed
52648516Clinical efficacy of recombinant human erythropoietin in hemodialysis patients.Semin Nephrol1989https://conductscience.org/library/papers/2648516PubMed
62890852Improvement in the haemostatic defect of uraemia after treatment with recombinant human erythropoietin.Lancet1987https://conductscience.org/library/papers/2890852PubMed
72567923Recombinant human erythropoietin treatment in patients on maintenance home haemodialysis.Lancet1989https://conductscience.org/library/papers/2567923PubMed
82569098Erythropoietin and autologous blood donation.Lancet1989https://conductscience.org/library/papers/2569098PubMed
92566852Pyruvate kinase deficiency and delayed clinical response to recombinant human erythropoietin treatment.Lancet1989https://conductscience.org/library/papers/2566852PubMed
103056862Clinical effect of recombinant human erythropoietin on anemia associated with chronic renal failure. A multi-institutional study in Japan.Int J Artif Organs1988https://conductscience.org/library/papers/3056862PubMed
113292144Blood pressure changes during treatment with recombinant human erythropoietin.Contrib Nephrol1988https://conductscience.org/library/papers/3292144PubMed
122730958Recombinant human erythropoietin and hematopoietic progenitor cells in vivo.Blood1989https://conductscience.org/library/papers/2730958PubMed
132688507Recombinant human erythropoietin in anemic patients with end-stage renal disease. Results of a phase III multicenter clinical trial.Ann Intern Med1989https://conductscience.org/library/papers/2688507PubMed
142648083
Cooperative effects of human recombinant granulocyte-macrophage colony stimulating factor and human recombinant erythropoietin in inducing erythroid differentiation of the human erythroleukaemia cell line K 562 clonogenic cells.
Leuk Res1989https://conductscience.org/library/papers/2648083PubMed
152570273Recombinant human erythropoietin treatment in patients on maintenance home haemodialysis.Lancet1989https://conductscience.org/library/papers/2570273PubMed
163672079[Successful treatment of anemia in hemolysis patients using recombinant human erythropoietin. Maintenance dosage and serum concentration].Schweiz Med Wochenschr1987https://conductscience.org/library/papers/3672079PubMed
172902395Early thrombosis in kidney grafted into patient treated with erythropoietin.Lancet1988https://conductscience.org/library/papers/2902395PubMed
182505185Kinetics of erythropoiesis in dialysis patients receiving recombinant erythropoietin treatment.Nephrol Dial Transplant1989https://conductscience.org/library/papers/2505185PubMed
193391027Treatment of polytransfused hemodialysis patients with recombinant human erythropoietin.Contrib Nephrol1988https://conductscience.org/library/papers/3391027PubMed
202779711Increased ultrafiltration after erythropoietin-induced correction of renal anemia in patients on continuous ambulatory peritoneal dialysis.Nephron1989https://conductscience.org/library/papers/2779711PubMed

See all 123 referencesDownload CSV of references

Cited by20

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 83 citations.

PMIDTitleJournalYearIn PapersSource
35278204An Introduction to Biosimilars for the Treatment of Retinal Diseases: A Narrative Review.Ophthalmol Ther2022https://conductscience.org/library/papers/35278204PubMed
24040481Circulating levels of erythropoietin and its relation to arterial stiffness in patients with hypertension.Int J Clin Exp Med2013https://conductscience.org/library/papers/24040481PubMed
23818131The pharmacology of regenerative medicine.Pharmacol Rev2013https://conductscience.org/library/papers/23818131PubMed
22729393Impact of erythropoiesis-stimulating agents on red blood cell transfusion in Korea.Int J Clin Pharm2012https://conductscience.org/library/papers/22729393PubMed
17722510Nanomedicines in the treatment of anemia in renal disease: focus on CERA (Continuous Erythropoietin Receptor Activator).Int J Nanomedicine2007https://conductscience.org/library/papers/17722510PubMed
14871172Epoetin Beta: a review of its clinical use in the treatment of anaemia in patients with cancer.Drugs2004https://conductscience.org/library/papers/14871172PubMed
10382935Clinical use of rHuEPO in bone marrow transplantation.Med Oncol1999https://conductscience.org/library/papers/10382935PubMed
10146987Epoetin: a pharmacoeconomic review of its use in chronic renal failure and its effects on quality of life.Pharmacoeconomics1993https://conductscience.org/library/papers/10146987PubMed
9285314Pharmacokinetics of recombinant human erythropoietin in children with chronic renal failure.Int Urol Nephrol1997https://conductscience.org/library/papers/9285314PubMed
9032980Bovine alpha s1-casein gene sequences direct high level expression of human granulocyte-macrophage colony-stimulating factor in the milk of transgenic mice.Transgenic Res1997https://conductscience.org/library/papers/9032980PubMed
8826532New peptide and protein drugs.Pharm World Sci1996https://conductscience.org/library/papers/8826532PubMed
8808169Epoetin beta. A review of its pharmacological properties and clinical use in the management of anaemia associated with chronic renal failure.Drugs1996https://conductscience.org/library/papers/8808169PubMed
8439481Pharmacokinetics of recombinant human erythropoietin applied subcutaneously to children with chronic renal failure.Pediatr Nephrol1993https://conductscience.org/library/papers/8439481PubMed
7729331Epoetin alfa. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in nonrenal applications.Drugs1995https://conductscience.org/library/papers/7729331PubMed
7706487Myoblast transfer of human erythropoietin gene in a mouse model of renal failure.J Clin Invest1995https://conductscience.org/library/papers/7706487PubMed
7579784Epoetin alfa. A review of its clinical efficacy in the management of anaemia associated with renal failure and chronic disease and its use in surgical patients.Drugs Aging1995https://conductscience.org/library/papers/7579784PubMed
7530630Filgrastim. A review of its pharmacological properties and therapeutic efficacy in neutropenia.Drugs1994https://conductscience.org/library/papers/7530630PubMed
2029809Clinical pharmacokinetics of epoetin (recombinant human erythropoietin).Clin Pharmacokinet1991https://conductscience.org/library/papers/2029809PubMed
1528712Is Recormon less painful than Eprex after subcutaneous administration?Pharm Weekbl Sci1992https://conductscience.org/library/papers/1528712PubMed
1493082The pharmacokinetics and pharmacodynamics of recombinant human erythropoietin in haemodialysis patients.Br J Clin Pharmacol1992https://conductscience.org/library/papers/1493082PubMed

Download CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
EPO2056PubTator's text mininghttps://conductscience.org/library/genes/2056NCBI Gene
TF7018PubTator's text mininghttps://conductscience.org/library/genes/7018NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/2693045

GET https://conductscience.org/api/papers/v1/2693045/references?page=2